Kenji Oki

582 total citations
18 papers, 347 citations indexed

About

Kenji Oki is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kenji Oki has authored 18 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kenji Oki's work include Hormonal Regulation and Hypertension (10 papers), Adrenal and Paraganglionic Tumors (6 papers) and Adrenal Hormones and Disorders (5 papers). Kenji Oki is often cited by papers focused on Hormonal Regulation and Hypertension (10 papers), Adrenal and Paraganglionic Tumors (6 papers) and Adrenal Hormones and Disorders (5 papers). Kenji Oki collaborates with scholars based in Japan, United States and Australia. Kenji Oki's co-authors include Nobuoki Kohno, Kiminori Yamane, Nozomu Kamei, Hideki Nojima, Shuhei Nakanishi, Tomokazu Awaya, Yasuyuki Nomura, Fumio Tsuji, Masaaki Murai and Minoru Sasano and has published in prestigious journals such as Circulation, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kenji Oki

17 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Oki Japan 12 156 115 98 65 53 18 347
Naoufel Nabli Tunisia 12 105 0.7× 126 1.1× 89 0.9× 78 1.2× 53 1.0× 27 345
Benjamin Assad Jaghutriz Germany 8 226 1.4× 116 1.0× 156 1.6× 87 1.3× 68 1.3× 12 410
Alena Šmahelová Czechia 12 215 1.4× 68 0.6× 121 1.2× 58 0.9× 49 0.9× 42 418
Deborah K. Oh United States 6 134 0.9× 218 1.9× 67 0.7× 165 2.5× 57 1.1× 11 456
Roman Trepp Switzerland 14 285 1.8× 71 0.6× 77 0.8× 157 2.4× 36 0.7× 38 530
Aydan Usman Türkiye 10 105 0.7× 158 1.4× 45 0.5× 113 1.7× 48 0.9× 28 384
Başak Karbek Türkiye 13 262 1.7× 41 0.4× 74 0.8× 48 0.7× 68 1.3× 22 438
Malgorzata Monika Brzozowska Australia 8 90 0.6× 93 0.8× 132 1.3× 124 1.9× 40 0.8× 22 352
Maria Andrikoula Greece 7 134 0.9× 61 0.5× 55 0.6× 70 1.1× 23 0.4× 15 338
Tomohito Izumi Japan 8 87 0.6× 140 1.2× 121 1.2× 106 1.6× 38 0.7× 20 417

Countries citing papers authored by Kenji Oki

Since Specialization
Citations

This map shows the geographic impact of Kenji Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Oki more than expected).

Fields of papers citing papers by Kenji Oki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Oki. The network helps show where Kenji Oki may publish in the future.

Co-authorship network of co-authors of Kenji Oki

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Oki. A scholar is included among the top collaborators of Kenji Oki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Oki. Kenji Oki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nakano, Eriko, Kosuke Mukai, Atsunori Fukuhara, et al.. (2024). Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation. Endocrine Journal. 71(5). 489–497.
2.
Inoue, Kosuke, Tatsuhiko Naito, Kyuto Sonehara, et al.. (2024). Primary Aldosteronism and Risk of Cardiovascular Outcomes: Genome‐Wide Association and Mendelian Randomization Study. Journal of the American Heart Association. 13(15). e034180–e034180. 7 indexed citations
3.
Naito, Tatsuhiko, Kosuke Inoue, Kyuto Sonehara, et al.. (2023). Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Studies. Circulation. 147(14). 1097–1109. 13 indexed citations
4.
Hirawa, Nobuhito, Yuichiro Yano, Kouichi Tamura, et al.. (2021). Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis. 324. 84–90. 13 indexed citations
5.
Okamoto, Kentaro, Youichi Ohno, Masakatsu Sone, et al.. (2021). Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?. Frontiers in Endocrinology. 12. 645395–645395. 3 indexed citations
6.
Oki, Kenji, et al.. (2020). Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung. ERJ Open Research. 6(4). 402–2020. 3 indexed citations
7.
Takakura, Yuji, Masatoshi Kochi, Kenji Oki, et al.. (2020). A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab. Case Reports in Oncology. 13(1). 200–206. 14 indexed citations
8.
Kishimoto, Shinji, Kenji Oki, Tatsuya Maruhashi, et al.. (2018). Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism. Journal of Hypertension. 37(5). 1083–1095. 11 indexed citations
9.
Matsumoto, Takeshi, Kenji Oki, Masato Kajikawa, et al.. (2015). Effect of Aldosterone-Producing Adenoma on Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism. Hypertension. 65(4). 841–848. 35 indexed citations
10.
Oki, Kenji, et al.. (2012). Influence of Adrenal Subclinical Hypercortisolism on Hypertension in Patients with Adrenal Incidentaloma. Experimental and Clinical Endocrinology & Diabetes. 120(4). 244–247. 16 indexed citations
11.
Oki, Kenji, et al.. (2011). Resistance to Thyroid Hormone Accompanied by Graves' Disease. Internal Medicine. 50(18). 1977–1980. 15 indexed citations
12.
Tsuji, Fumio, Masaaki Murai, Kenji Oki, et al.. (2010). Effects of SA13353, a Transient Receptor Potential Vanilloid 1 Agonist, on Leukocyte Infiltration in Lipopolysaccharide-Induced Acute Lung Injury and Ovalbumin-Induced Allergic Airway Inflammation. Journal of Pharmacological Sciences. 112(4). 487–490. 20 indexed citations
13.
Oki, Kenji, Kiminori Yamane, Nozomu Kamei, et al.. (2008). Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas. Clinical and Experimental Nephrology. 12(5). 382–387. 13 indexed citations
14.
15.
Oki, Kenji, Kiminori Yamane, Nozomu Kamei, Hideki Nojima, & Nobuoki Kohno. (2007). Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clinical Endocrinology. 67(5). 796–800. 121 indexed citations
16.
Oki, Kenji, Kiminori Yamane, Masayasu Yoneda, et al.. (2007). A Case of Addison's Disease Confirmed with Low Dose Cosyntropin Stimulation Test. Endocrine Journal. 54(5). 765–769. 2 indexed citations
17.
Oki, Kenji, Kiminori Yamane, Junko Koide, et al.. (2006). A Case of Polyglandular Autoimmune Syndrome Type III Complicated with Autoimmune Hepatitis. Endocrine Journal. 53(5). 705–709. 21 indexed citations
18.
Nomura, Yasuyuki, et al.. (1982). Influence of repeated administration of desmethylimipramine on beta adrenergic and muscarinic cholinergic receptors and 45Ca++ binding to sarcoplasmic reticulum in the rat heart.. Journal of Pharmacology and Experimental Therapeutics. 223(3). 834–840. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoufel Nabli Breakdown of academic impact, for papers by Benjamin Assad Jaghutriz Breakdown of academic impact, for papers by Alena Šmahelová Breakdown of academic impact, for papers by Deborah K. Oh Breakdown of academic impact, for papers by Roman Trepp Breakdown of academic impact, for papers by Aydan Usman Breakdown of academic impact, for papers by Başak Karbek Breakdown of academic impact, for papers by Malgorzata Monika Brzozowska Breakdown of academic impact, for papers by Maria Andrikoula Breakdown of academic impact, for papers by Tomohito Izumi
Rankless by CCL
2026